Literature DB >> 25898957

Lung Cancer Workshop XI: Tobacco-Induced Disease: Advances in Policy, Early Detection and Management.

James L Mulshine1, Rick Avila2, David Yankelevitz3, Thomas M Baer4, Raul San Jose Estépar5, Laurie Fenton Ambrose6, Carolyn R Aldigé7.   

Abstract

The Prevent Cancer Foundation Lung Cancer Workshop XI: Tobacco-Induced Disease: Advances in Policy, Early Detection and Management was held in New York, NY on May 16 and 17, 2014. The two goals of the Workshop were to define strategies to drive innovation in precompetitive quantitative research on the use of imaging to assess new therapies for management of early lung cancer and to discuss a process to implement a national program to provide high quality computed tomography imaging for lung cancer and other tobacco-induced disease. With the central importance of computed tomography imaging for both early detection and volumetric lung cancer assessment, strategic issues around the development of imaging and ensuring its quality are critical to ensure continued progress against this most lethal cancer.

Entities:  

Mesh:

Year:  2015        PMID: 25898957      PMCID: PMC4408905          DOI: 10.1097/JTO.0000000000000489

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  20 in total

1.  Data sets for the qualification of volumetric CT as a quantitative imaging biomarker in lung cancer.

Authors:  A J Buckler; L H Schwartz; N Petrick; M McNitt-Gray; B Zhao; C Fenimore; A P Reeves; P D Mozley; R S Avila
Journal:  Opt Express       Date:  2010-07-05       Impact factor: 3.894

Review 2.  Developing CT image-processing tools to accelerate progress in lung cancer drug development.

Authors:  James L Mulshine; Ricardo S Avila; Fred R Hirsch; David Yankelevitz
Journal:  Oncology (Williston Park)       Date:  2006-11       Impact factor: 2.990

3.  Breast density: comparison of chest CT with mammography.

Authors:  Mary Salvatore; Laurie Margolies; Minal Kale; Juan Wisnivesky; Sean Kotkin; Claudia I Henschke; David F Yankelevitz
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

4.  Application of high-resolution CT imaging data to lung cancer drug development: measuring progress: workshop IX.

Authors:  James L Mulshine; Rick Avila; David Yankelevitz; Thomas M Baer; Raul San Jose Estepar; Laurie Fenton; Carolyn R Aldige
Journal:  J Thorac Oncol       Date:  2013-11       Impact factor: 15.609

5.  ACR CT accreditation program and the lung cancer screening program designation.

Authors:  Ella A Kazerooni; Mark R Armstrong; Judith K Amorosa; Dina Hernandez; Lawrence A Liebscher; Hrudaya Nath; Michael F McNitt-Gray; Eric J Stern; Pamela A Wilcox
Journal:  J Am Coll Radiol       Date:  2014-11-20       Impact factor: 5.532

Review 6.  The use of volumetric CT as an imaging biomarker in lung cancer.

Authors:  Andrew J Buckler; James L Mulshine; Ronald Gottlieb; Binsheng Zhao; P David Mozley; Lawrence Schwartz
Journal:  Acad Radiol       Date:  2010-01       Impact factor: 3.173

7.  Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer.

Authors:  Raja M Flores; Bernard J Park; Joseph Dycoco; Anna Aronova; Yael Hirth; Nabil P Rizk; Manjit Bains; Robert J Downey; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07       Impact factor: 5.209

8.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

9.  Radiation dose reduction for CT lung cancer screening using ASIR and MBIR: a phantom study.

Authors:  Kelsey B Mathieu; Hua Ai; Patricia S Fox; Myrna Cobos Barco Godoy; Reginald F Munden; Patricia M de Groot; Tinsu Pan
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102

10.  A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.

Authors:  Andrea C Villanti; Yiding Jiang; David B Abrams; Bruce S Pyenson
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.